This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnston, D. Articles by Steinberg, B. M. Search for Related Content PubMed PubMed Citation Articles by Johnston, D. Articles by Steinberg, B. M.

Elevation of the Epidermal Growth Factor Receptor and Dependent Signaling in Human Papillomavirus-infected Laryngeal Papillomas¹

Department of Otolaryngology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York 11040

Laryngeal papillomas are benign tumors caused by human papillomaviruses types 6 and 11. This study addressed alterations in levels of signal transduction from the epidermal growth factor receptor (EGFR) in papillomas and cultured papilloma cells compared to normal tissue and cells. Mitogen-activated protein kinase (MAPK) was activated to a greater extent, phosphotyrosine was more abundant, and EGFR was overexpressed in laryngeal papillomas compared to normal laryngeal epithelium by Western blot analysis. The EGFR was 3 times more abundant in cultured papilloma cells than in normal laryngeal cells by Scatchard analysis and Western blot, without gene amplification or an increase in steady-state levels of mRNA. Following stimulation with EGF, a significant portion of the EGFR was recycled to the surface in papilloma cells, whereas in normal cells, it was not. Tyrosine kinase activity and activation of MAPK was more responsive to epidermal growth factor stimulation in papilloma cells than in uninfected primary laryngeal cells. PD153035, a specific inhibitor of the EGFR, and an EGFR-specific antibody that blocks ligand binding completely abrogated basal MAPK activation by endogenous ligands in laryngeal papilloma cells. These results demonstrated that infection of laryngeal epithelium by low-risk human papillomaviruses elevates the EGFR by posttranslational mechanisms, increasing its responsiveness to ligand-mediated activation. They also showed that MAPK activation in laryngeal papillomas depends upon ligand-mediated EGFR stimulation.

This article has been cited by other articles:

				A. Limsukon, I. Susanto, G. W. S. Hoo, S. M. Dubinett, and R. K. Batra Regression of Recurrent Respiratory Papillomatosis With Celecoxib and Erlotinib Combination Therapy Chest, September 1, 2009; 136(3): 924 - 926. [Abstract] [Full Text] [PDF]

				B. Kumar, K. G. Cordell, J. S. Lee, F. P. Worden, M. E. Prince, H. H. Tran, G. T. Wolf, S. G. Urba, D. B. Chepeha, T. N. Teknos, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer J. Clin. Oncol., July 1, 2008; 26(19): 3128 - 3137. [Abstract] [Full Text] [PDF]

				X. Tang, Q. Zhang, J. Nishitani, J. Brown, S. Shi, and A. D. Le Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Hypoxia-Inducible Factor 1{alpha} Protein Accumulation and Vascular Endothelial Growth Factor Expression in Human Cervical Carcinoma Cells Clin. Cancer Res., May 1, 2007; 13(9): 2568 - 2576. [Abstract] [Full Text] [PDF]

				R. Wu, A. L. Abramson, M. J. Shikowitz, A. J. Dannenberg, and B. M. Steinberg Epidermal Growth Factor-Induced Cyclooxygenase-2 Expression Is Mediated through Phosphatidylinositol-3 Kinase, Not Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase, in Recurrent Respiratory Papillomas Clin. Cancer Res., September 1, 2005; 11(17): 6155 - 6161. [Abstract] [Full Text] [PDF]

				B. Bostrom, J. Sidman, S. Marker, T. Lander, and D. Drehner Gefitinib Therapy for Life-Threatening Laryngeal Papillomatosis Arch Otolaryngol Head Neck Surg, January 1, 2005; 131(1): 64 - 67. [Full Text] [PDF]

				F. Fehrmann, D. J. Klumpp, and L. A. Laimins Human Papillomavirus Type 31 E5 Protein Supports Cell Cycle Progression and Activates Late Viral Functions upon Epithelial Differentiation J. Virol., March 1, 2003; 77(5): 2819 - 2831. [Abstract] [Full Text] [PDF]

				S. Sun and B. M. Steinberg PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells J. Gen. Virol., June 1, 2002; 83(7): 1651 - 1658. [Abstract] [Full Text] [PDF]

				I. Vancurova, R. Wu, V. Miskolci, and S. Sun Increased p50/p50 NF-{kappa}B Activation in Human Papillomavirus Type 6- or Type 11-Induced Laryngeal Papilloma Tissue J. Virol., February 1, 2002; 76(3): 1533 - 1536. [Abstract] [Full Text] [PDF]

				G. Almadori, G. Cadoni, P. Cattani, J. Galli, F. Bussu, G. Ferrandina, G. Scambia, G. Fadda, and M. Maurizi Human Papillomavirus Infection and Epidermal Growth Factor Receptor Expression in Primary Laryngeal Squamous Cell Carcinoma Clin. Cancer Res., December 1, 2001; 7(12): 3988 - 3993. [Abstract] [Full Text] [PDF]

				C. D. Woodworth, D. Gaiotti, E. Michael, L. Hansen, and M. Nees Targeted Disruption of the Epidermal Growth Factor Receptor Inhibits Development of Papillomas and Carcinomas from Human Papillomavirus-immortalized Keratinocytes Cancer Res., August 1, 2000; 60(16): 4397 - 4402. [Abstract] [Full Text]

				P. Zhang and B. M. Steinberg Overexpression of PTEN/MMAC1 and Decreased Activation of Akt in Human Papillomavirus-infected Laryngeal Papillomas Cancer Res., March 1, 2000; 60(5): 1457 - 1462. [Abstract] [Full Text]